{"database": "lobbying", "table": "lobbying_activities", "rows": [[1771545, "ad0143e1-458a-4526-8583-fe9b3f464fd8", "Q4", "THE CHARLES GROUP, LLC", 53458, "WESTPORT PHARMACEUTICALS, LLC", 2015, "fourth_quarter", "SCI", "treatment of nonconvertible pharmaceutical products under US counternarcotics laws", "Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE", null, null, 0, 0, "2016-01-18T17:13:59.023000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1771545"], "units": {}, "query_ms": 0.569600029848516, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}